These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29471344)

  • 1. Cross-border issues: an important component of onchocerciasis elimination programmes.
    Bush S; Sodahlon Y; Downs P; Mackenzie CD
    Int Health; 2018 Mar; 10(suppl_1):i54-i59. PubMed ID: 29471344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Cross-border collaboration in onchocerciasis elimination in Uganda: progress, challenges and opportunities from 2008 to 2013".
    Lakwo T; Ukety T; Bakajika D; Tukahebwa E; Awaca P; Amazigo U
    Global Health; 2018 Feb; 14(1):16. PubMed ID: 29409509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing quality assured (QA) laboratory support for onchocerciasis elimination in Africa.
    Shott J; Ducker C; Unnasch TR; Mackenzie CD
    Int Health; 2018 Mar; 10(suppl_1):i33-i39. PubMed ID: 29471345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mectizan Donation Program (MDP).
    Thylefors B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress toward elimination of onchocerciasis in the Americas.
    Sauerbrey M; Rakers LJ; Richards FO
    Int Health; 2018 Mar; 10(suppl_1):i71-i78. PubMed ID: 29471334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
    Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
    Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-border collaboration for neglected tropical disease efforts-Lessons learned from onchocerciasis control and elimination in the Mano River Union (West Africa).
    Gustavsen K; Sodahlon Y; Bush S
    Global Health; 2016 Aug; 12(1):44. PubMed ID: 27549911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of national committees in eliminating onchocerciasis.
    Griswold E; Unnasch T; Eberhard M; Nwoke BEB; Morales Z; Muheki Tukahebwa E; Kebede B; Anagbogu I; Katabarwa M; Habomugisha P; Tadesse Z; Miri ES; Evans D; Cohn D; Elhassan E; Richards F
    Int Health; 2018 Mar; 10(suppl_1):i60-i70. PubMed ID: 29471337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onchocerciasis: shifting the target from control to elimination requires a new first-step-elimination mapping.
    Rebollo MP; Zoure H; Ogoussan K; Sodahlon Y; Ottesen EA; Cantey PT
    Int Health; 2018 Mar; 10(suppl_1):i14-i19. PubMed ID: 29471341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From river blindness control to elimination: bridge over troubled water.
    Colebunders R; Basáñez MG; Siling K; Post RJ; Rotsaert A; Mmbando B; Suykerbuyk P; Hopkins A
    Infect Dis Poverty; 2018 Mar; 7(1):21. PubMed ID: 29587844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis.
    Kelly-Hope L; Paulo R; Thomas B; Brito M; Unnasch TR; Molyneux D
    Parasit Vectors; 2017 Apr; 10(1):172. PubMed ID: 28381279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
    Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
    Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
    Kim YE; Sicuri E; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(9):e0004056. PubMed ID: 26360917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onchocerciasis in Yemen: moving forward towards an elimination program.
    Al-Kubati AS; Mackenzie CD; Boakye D; Al-Qubati Y; Al-Samie AR; Awad IE; Thylefors B; Hopkins A
    Int Health; 2018 Mar; 10(suppl_1):i89-i96. PubMed ID: 29471343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
    Kamgno J; Nana-Djeunga HC; Pion SD; Chesnais CB; Klion AD; Mackenzie CD; Nutman TB; Boussinesq M
    Int Health; 2018 Mar; 10(suppl_1):i49-i53. PubMed ID: 29471340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions.
    Colebunders R; Stolk WA; Siewe Fodjo JN; Mackenzie CD; Hopkins A
    Infect Dis Poverty; 2019 Oct; 8(1):83. PubMed ID: 31578157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance.
    Guevara Á; Lovato R; Proaño R; Rodriguez-Perez MA; Unnasch T; Cooper PJ; Guderian RH
    Parasit Vectors; 2018 Apr; 11(1):265. PubMed ID: 29690907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitioning from river blindness control to elimination: steps toward stopping treatment.
    Cantey PT; Roy SL; Boakye D; Mwingira U; Ottesen EA; Hopkins AD; Sodahlon YK
    Int Health; 2018 Mar; 10(suppl_1):i7-i13. PubMed ID: 29471338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. For as Long as Necessary: Examining 30 years of MSD's Focus on Achieving Elimination of Onchocerciasis and Lymphatic Filariasis.
    Gustavsen KM; Colatrella BD; McCoy T
    Int Health; 2018 Mar; 10(suppl_1):i3-i6. PubMed ID: 29186497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.